Isolation, characterization and mobilization of prostate cancer tissue derived CD133 +MDR1 + cells

Journal of Stem Cells

Volumn 5, Issue 2, 2011, Pages 75-81

  Rentala, Satyanarayana ^a   Mangamoori, Lakshmi Narasu ^b  

^a GITAM UNIVERSITY   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

CD133; CD44; Multi drug resistance1 (MDR1) and CXCR4; Prostate cancer stem cells

Indexed keywords

CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HERMES ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; OCTAMER TRANSCRIPTION FACTOR 4; STROMAL CELL DERIVED FACTOR 1ALPHA; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; AGED; ARTICLE; CANCER STEM CELL; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROSTATE CANCER; STEM CELL MOBILIZATION; WESTERN BLOTTING;

ANTIGENS, CD; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CXCL12; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; NEOPLASTIC STEM CELLS; P-GLYCOPROTEIN; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 79961175449     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nakai E, Park K, Yawata T, Chihara T, Kumazawa A et al., Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma, Cancer Invest. 2009 Nov;27(9):901-8.
2. Sigal Tavor, Isabelle Petit, Svetlana Porozov, Abraham Avigdor, Ayelet Dar et al., CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice, Cancer research, 2004, 64, 2817-2824.
3. SH Lang, FM Frame and AT Collins, Prostate cancer stem cells, J Pathol 2009; 217: 299-306.
4. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl. J. Med. 2006; 355: 1253-1261.
5. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene 2001; 20: 8085-8091.
6. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003; 4: 361-370.
7. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al., Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005; 65: 5506-5511.
8. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp. Med. 1996; 183: 1797-1806.
9. Jin T, Branch DR, Zhang X, Qi S, Youngson B, Goss PE. Examination of POU homeobox gene expression in human breast cancer cells. Int. J. Cancer 1999; 81: 104-112.
10. Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem. J. 2003; 375: 199-205.
11. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317.
12. Park I.H, Zhao R, West JA, Yabuuchi A, Huo H, et al., Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141-146.
13. Kawabata S, Oka M, Soda H, Shiozawa K, Nakatomi K, et al., Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin. Cancer Res. 2003; 9: 3052-3057.
14. Elena Monzani, Floriana Facchetti, Enrico Galmozzi; Elena Corsini, Anna Benetti, et al., Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential Eur. J. Cancer 2007; 43: 935-946.
15. Yu J, Vodyanik, MA Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
16. Satyanarayana Rentala, Murali Mohan Sagar Balla, Satish Khurana and Asok Mukhopadhaya. MDR1 gene expression enhances long-term engraftibility of cultured bone marrow cells Biochemical and Biophysical Research Communications. 2005; 335: 957-964.
17. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al., Cancer stem cells: perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res., 2006; 66:9339-9344.
18. Elkind NB, Szentpétery Z, Apáti A, Ozvegy-Laczka C, Várady G, Olga Ujhelly, et al., Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib). Cancer Res. 2005; 65: 1770-1777.